Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Lovega LLC dba Pink Pony Peptides
WARNING LETTER
•Lovega LLC dba Pink Pony Peptides•December 31, 2025

Lovega LLC dba Pink Pony Peptides – FDA Warning Letter, Dec 31, 2025

Record Details

On March 31, 2026, the FDA issued a warning letter to Lovega LLC, doing business as Pink Pony Peptides, following an investigation of the company’s website in December 2025. The FDA determined that the firm is illegally selling unapproved new drugs, including injectable products marketed as "GLP-2 TZ" (Tirzepatide), "GLP-3 RT" (Retatrutide), and "Bacteriostatic Water."

Under the Federal Food, Drug, and Cosmetic Act, these products are classified as drugs because they are intended to treat medical conditions, regulate blood sugar, and support weight loss. Although Pink Pony Peptides labeled these items for "research purposes only," their website marketing explicitly suggests human use. The FDA highlighted that injectable drugs pose significant public health risks because they bypass the body’s natural defenses, potentially leading to life-threatening infections if they are not properly regulated and manufactured.

By selling these products without approved applications, the company has violated federal laws regarding the introduction of unapproved new drugs into interstate commerce. The FDA has mandated that Lovega LLC provide a written response within 15 working days detailing the corrective actions taken to address these violations. Failure to comply could result in legal consequences, including product seizure or an injunction.

Company
Lovega LLC dba Pink Pony Peptides
Inspection date
December 31, 2025
Product type
drugs
Office
Office of Unapproved Drugs & Labeling Compliance
People
  • Susan Vega
  • Tina Smith (Director)
View Company Profile

ID · 00847e44-d025-443a-92be-cd2f07678f17

Violation Codes10
FD&C Act 505(a)21 U.S.C. 355(a)FD&C Act 301(d) of the FD&C Act21 U.S.C. 331(dd)FD&C Act 201(g)(1)21 U.S.C. 321(g)(1)FD&C Act 201(p)FD&C Act 50521 U.S.C. 35521 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lovega LLC dba Pink Pony Peptides
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.